Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)
NCT04160117
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
202
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Recurrence
Interventions
DRUG:
Colchicine 0.6 mg
DRUG:
Matching placebo
Sponsor
Population Health Research Institute